Sagar Patel, DO
Interventional Cardiology · Brick, NJNPI 1841653078
Payments from drug & device makers
Across 139 payments — averaging $36.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$830
- Abbott$742
- Shockwave Medical, Inc$651
- Medtronic$647
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$260
- BD$245
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,31685%
- Education$75115%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 25 | $830 |
| Abbott | 17 | $742 |
| Shockwave Medical, Inc | 12 | $651 |
| Medtronic | 10 | $647 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $260 |
| BD | 2 | $245 |
| Abiomed | 3 | $188 |
| Boehringer Ingelheim | 8 | $171 |
| Boston Scientific | 2 | $166 |
| Novo Nordisk | 12 | $158 |
| Davol Inc. | 1 | $150 |
| Lilly USA, LLC | 2 | $140 |
| Pfizer | 6 | $103 |
| Atricure, Inc. | 1 | $77 |
| Getinge USA Sales, LLC | 1 | $72 |
| Alnylam Pharmaceuticals Inc. | 3 | $54 |
| Endologix LLC | 1 | $49 |
| Terumo Medical Corporation | 2 | $47 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $44 |
| Cvrx, Inc. | 2 | $33 |
| Merck | 2 | $31 |
| Amgen | 2 | $29 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Edwards Lifesciences | 1 | $20 |
| Penumbra, Inc. | 1 | $19 |
| Scpharmaceuticals Inc. | 1 | $18 |
| Biotronik Inc. | 1 | $18 |
| Lexicon Pharmaceuticals, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Angiodynamics, Inc. | 1 | $15 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,068 in reported general payments places this provider in the 30th percentile of 166 interventional cardiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 133 | $194,311 |
| XareltoRivaroxaban | 32 | $48,963 |
| EntrestoSacubitril/Valsartan | 34 | $37,523 |
| FarxigaDapagliflozin Propanediol | 44 | $34,665 |
| BrilintaTicagrelor | 31 | $18,225 |
| Repatha SureclickEvolocumab | 16 | $17,499 |
| JardianceEmpagliflozin | 13 | $13,936 |
| OzempicSemaglutide | 12 | $11,541 |
| Metoprolol Succinate | 186 | $2,942 |
| Rosuvastatin Calcium | 201 | $2,683 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 87 | $2,595 |
| ClopidogrelClopidogrel Bisulfate | 140 | $2,269 |
| Torsemide | 92 | $1,767 |
| Atorvastatin Calcium | 107 | $1,700 |
| Carvedilol | 128 | $1,626 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $103 | $194,311133 claims |
| AstraZenecaFarxiga, Brilinta | $830 | $52,89075 claims |
| Johnson & JohnsonXarelto | $15 | $48,96332 claims |
| Boehringer IngelheimJardiance | $171 | $13,93613 claims |
| Novo NordiskOzempic | $158 | $11,54112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 166 interventional cardiology providers in New Jersey.
Other interventional cardiology in Brick
- Hormoz KianfarBrick$19K
- Dinesh SingalSomerset$1.4M
- Ankitkumar PatelGlen Ridge$717K
- Matthew SayboltEatontown$671K
- Jaffar RazaSecaucus$537K
- Kintur SanghviBordentown$467K
- Ziad AbbudOcean$361K
- Ramin HastingsHasbrouck Heights$355K
- Ryan KapleHackensack$280K
- Haroon FarazTeaneck$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.